These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25232744)

  • 1. De novo TBR1 mutations in sporadic autism disrupt protein functions.
    Deriziotis P; O'Roak BJ; Graham SA; Estruch SB; Dimitropoulou D; Bernier RA; Gerdts J; Shendure J; Eichler EE; Fisher SE
    Nat Commun; 2014 Sep; 5():4954. PubMed ID: 25232744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of TBR1 variants in neurodevelopmental disorder.
    den Hoed J; Sollis E; Venselaar H; Estruch SB; Deriziotis P; Fisher SE
    Sci Rep; 2018 Sep; 8(1):14279. PubMed ID: 30250039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the TBR1 interactome: variants associated with neurodevelopmental disorders disrupt novel protein interactions.
    Sollis E; den Hoed J; Quevedo M; Estruch SB; Vino A; Dekkers DHW; Demmers JAA; Poot R; Deriziotis P; Fisher SE
    Hum Mol Genet; 2023 Apr; 32(9):1497-1510. PubMed ID: 36579832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.
    Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P
    Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in TBR1 gene leads to cortical malformations and intellectual disability.
    Vegas N; Cavallin M; Kleefstra T; de Boer L; Philbert M; Maillard C; Boddaert N; Munnich A; Hubert L; Bery A; Besmond C; Bahi-Buisson N
    Eur J Med Genet; 2018 Dec; 61(12):759-764. PubMed ID: 30268909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
    Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL
    Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genetic analysis of mutations implicated in a human speech and language disorder.
    Vernes SC; Nicod J; Elahi FM; Coventry JA; Kenny N; Coupe AM; Bird LE; Davies KE; Fisher SE
    Hum Mol Genet; 2006 Nov; 15(21):3154-67. PubMed ID: 16984964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo frameshift pathogenic variant in TBR1 identified in autism without intellectual disability.
    Sapey-Triomphe LA; Reversat J; Lesca G; Chatron N; Bussa M; Mazoyer S; Schmitz C; Sonié S; Edery P
    Hum Genomics; 2020 Sep; 14(1):32. PubMed ID: 32948248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder.
    Kim DS; Burt AA; Ranchalis JE; Wilmot B; Smith JD; Patterson KE; Coe BP; Li YK; Bamshad MJ; Nikolas M; Eichler EE; Swanson JM; Nigg JT; Nickerson DA; Jarvik GP;
    Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):381-389. PubMed ID: 28332277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.
    Reuter MS; Riess A; Moog U; Briggs TA; Chandler KE; Rauch A; Stampfer M; Steindl K; Gläser D; Joset P; ; Krumbiegel M; Rabe H; Schulte-Mattler U; Bauer P; Beck-Wödl S; Kohlhase J; Reis A; Zweier C
    J Med Genet; 2017 Jan; 54(1):64-72. PubMed ID: 27572252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
    Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TBR1-related autistic-spectrum-disorder phenotype and its clinical spectrum.
    McDermott JH; Study DDD; Clayton-Smith J; Briggs TA
    Eur J Med Genet; 2018 May; 61(5):253-256. PubMed ID: 29288087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits.
    MacDermot KD; Bonora E; Sykes N; Coupe AM; Lai CS; Vernes SC; Vargha-Khadem F; McKenzie F; Smith RL; Monaco AP; Fisher SE
    Am J Hum Genet; 2005 Jun; 76(6):1074-80. PubMed ID: 15877281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
    O'Roak BJ; Vives L; Fu W; Egertson JD; Stanaway IB; Phelps IG; Carvill G; Kumar A; Lee C; Ankenman K; Munson J; Hiatt JB; Turner EH; Levy R; O'Day DR; Krumm N; Coe BP; Martin BK; Borenstein E; Nickerson DA; Mefford HC; Doherty D; Akey JM; Bernier R; Eichler EE; Shendure J
    Science; 2012 Dec; 338(6114):1619-22. PubMed ID: 23160955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare inherited missense variants of POGZ associate with autism risk and disrupt neuronal development.
    Zhao W; Tan J; Zhu T; Ou J; Li Y; Shen L; Wu H; Han L; Liu Y; Jia X; Bai T; Li H; Ke X; Zhao J; Zou X; Hu Z; Guo H; Xia K
    J Genet Genomics; 2019 May; 46(5):247-257. PubMed ID: 31196716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared and Distinct Functional Effects of Patient-Specific
    Co M; Barnard RA; Jahncke JN; Grindstaff S; Fedorov LM; Adey AC; Wright KM; O'Roak BJ
    J Neurosci; 2022 Sep; 42(37):7166-7181. PubMed ID: 35944998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders.
    Chen S; Fragoza R; Klei L; Liu Y; Wang J; Roeder K; Devlin B; Yu H
    Nat Genet; 2018 Jul; 50(7):1032-1040. PubMed ID: 29892012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.
    Marco EJ; Aitken AB; Nair VP; da Gente G; Gerdes MR; Bologlu L; Thomas S; Sherr EH
    BMC Med Genomics; 2018 May; 11(1):50. PubMed ID: 29801487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.